APO Research

APO RESEARCH · REPORT

Autism Spectrum Disorder Screening Service

Selected research

Market Outlook & Growth Opportunities

Global Autism Spectrum Disorder Screening Service Market Outlook and Growth Opportunities 2026

Market perspective

The global Autism Spectrum Disorder Screening Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Autism Spectrum Disorder Screening Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Autism Spectrum Disorder Screening Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Autism Spectrum Disorder Screening Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Autism Spectrum Disorder Screening Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Autism Spectrum Disorder Screening Service market include Autism Speaks, Mayo Clinic, Children's Hospital of Philadelphia, Kaiser Permanente, Cleveland Clinic, Mind Institute at UC Davis and Guangdong Jinglan Technology Industry Holding Group, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Autism Spectrum Disorder Screening Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Autism Spectrum Disorder Screening Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Autism Spectrum Disorder Screening Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Autism Spectrum Disorder Screening Service market.

Autism Spectrum Disorder Screening Service Segment by Company

Autism Speaks

Mayo Clinic

Children's Hospital of Philadelphia

Kaiser Permanente

Cleveland Clinic

Mind Institute at UC Davis

Guangdong Jinglan Technology Industry Holding Group

Autism Spectrum Disorder Screening Service Segment by Type

Developmental Screening Service

Behavioral Assessment Service

Autism Spectrum Disorder Screening Service Segment by Application

Child

Aldult

Autism Spectrum Disorder Screening Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Autism Spectrum Disorder Screening Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Autism Spectrum Disorder Screening Service key companies, revenue, market share, and recent developments.

3. To split the Autism Spectrum Disorder Screening Service breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Autism Spectrum Disorder Screening Service market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Autism Spectrum Disorder Screening Service significant trends, drivers, influence factors in global and regions.

6. To analyze Autism Spectrum Disorder Screening Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Autism Spectrum Disorder Screening Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Autism Spectrum Disorder Screening Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Autism Spectrum Disorder Screening Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Autism Spectrum Disorder Screening Service industry.

Chapter 3: Detailed analysis of Autism Spectrum Disorder Screening Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Autism Spectrum Disorder Screening Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Autism Spectrum Disorder Screening Service in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Autism Spectrum Disorder Screening Service Industry Trends Table 2. Autism Spectrum Disorder Screening Service Industry Drivers Table 3. Autism Spectrum Disorder Screening Service Industry Opportunities and Challenges Table 4. Autism Spectrum Disorder Screening Service Industry Restraints Table 5. Global Autism Spectrum Disorder Screening Service Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Autism Spectrum Disorder Screening Service Revenue Share by Company (2021-2026) Table 7. Global Autism Spectrum Disorder Screening Service Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Autism Spectrum Disorder Screening Service Key Company Manufacturing Base & Headquarters Table 9. Global Autism Spectrum Disorder Screening Service Company, Product Type & Application Table 10. Global Autism Spectrum Disorder Screening Service Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Autism Spectrum Disorder Screening Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Developmental Screening Service Table 15. Significant Companies of Behavioral Assessment Service Table 16. Global Autism Spectrum Disorder Screening Service Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Autism Spectrum Disorder Screening Service Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Autism Spectrum Disorder Screening Service Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Autism Spectrum Disorder Screening Service Sales Value Share by Type (2021-2026) Table 20. Global Autism Spectrum Disorder Screening Service Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Child Table 22. Significant Companies of Aldult Table 23. Global Autism Spectrum Disorder Screening Service Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 24. Global Autism Spectrum Disorder Screening Service Sales Value by Application (2021-2026) & (US$ Million) Table 25. Global Autism Spectrum Disorder Screening Service Sales Value by Application (2027-2032) & (US$ Million) Table 26. Global Autism Spectrum Disorder Screening Service Sales Value Share by Application (2021-2026) Table 27. Global Autism Spectrum Disorder Screening Service Sales Value Share by Application (2027-2032) Table 28. Global Autism Spectrum Disorder Screening Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Autism Spectrum Disorder Screening Service Sales Value by Region (2021-2026) & (US$ Million) Table 30. Global Autism Spectrum Disorder Screening Service Sales Value Share by Region (2021-2026) Table 31. Global Autism Spectrum Disorder Screening Service Sales Value by Region (2027-2032) & (US$ Million) Table 32. Global Autism Spectrum Disorder Screening Service Sales Value Share by Region (2027-2032) Table 33. Global Autism Spectrum Disorder Screening Service Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Autism Spectrum Disorder Screening Service Sales Value by Country (2021-2026) & (US$ Million) Table 35. Global Autism Spectrum Disorder Screening Service Sales Value Market Share by Country (2021-2026) Table 36. Global Autism Spectrum Disorder Screening Service Sales Value by Country (2027-2032) & (US$ Million) Table 37. Global Autism Spectrum Disorder Screening Service Sales Value Market Share by Country (2027-2032) Table 38. Autism Speaks Company Information Table 39. Autism Speaks Business Overview Table 40. Autism Speaks Autism Spectrum Disorder Screening Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 41. Autism Speaks Autism Spectrum Disorder Screening Service Product Portfolio Table 42. Autism Speaks Recent Development Table 43. Mayo Clinic Company Information Table 44. Mayo Clinic Business Overview Table 45. Mayo Clinic Autism Spectrum Disorder Screening Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Mayo Clinic Autism Spectrum Disorder Screening Service Product Portfolio Table 47. Mayo Clinic Recent Development Table 48. Children's Hospital of Philadelphia Company Information Table 49. Children's Hospital of Philadelphia Business Overview Table 50. Children's Hospital of Philadelphia Autism Spectrum Disorder Screening Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Children's Hospital of Philadelphia Autism Spectrum Disorder Screening Service Product Portfolio Table 52. Children's Hospital of Philadelphia Recent Development Table 53. Kaiser Permanente Company Information Table 54. Kaiser Permanente Business Overview Table 55. Kaiser Permanente Autism Spectrum Disorder Screening Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. Kaiser Permanente Autism Spectrum Disorder Screening Service Product Portfolio Table 57. Kaiser Permanente Recent Development Table 58. Cleveland Clinic Company Information Table 59. Cleveland Clinic Business Overview Table 60. Cleveland Clinic Autism Spectrum Disorder Screening Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. Cleveland Clinic Autism Spectrum Disorder Screening Service Product Portfolio Table 62. Cleveland Clinic Recent Development Table 63. Mind Institute at UC Davis Company Information Table 64. Mind Institute at UC Davis Business Overview Table 65. Mind Institute at UC Davis Autism Spectrum Disorder Screening Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Mind Institute at UC Davis Autism Spectrum Disorder Screening Service Product Portfolio Table 67. Mind Institute at UC Davis Recent Development Table 68. Guangdong Jinglan Technology Industry Holding Group Company Information Table 69. Guangdong Jinglan Technology Industry Holding Group Business Overview Table 70. Guangdong Jinglan Technology Industry Holding Group Autism Spectrum Disorder Screening Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Guangdong Jinglan Technology Industry Holding Group Autism Spectrum Disorder Screening Service Product Portfolio Table 72. Guangdong Jinglan Technology Industry Holding Group Recent Development Table 73. Research Programs/Design for This Report Table 74. Authors List of This Report Table 75. Secondary Sources Table 76. Primary Sources List of Figures Figure 1. Autism Spectrum Disorder Screening Service Product Image Figure 2. Global Autism Spectrum Disorder Screening Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Autism Spectrum Disorder Screening Service Market Size (2021-2032) & (US$ Million) Figure 4. Global Autism Spectrum Disorder Screening Service Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Developmental Screening Service Image Figure 8. Behavioral Assessment Service Image Figure 9. Global Autism Spectrum Disorder Screening Service Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Autism Spectrum Disorder Screening Service Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Autism Spectrum Disorder Screening Service Sales Value Share by Type (2021-2032) Figure 12. Child Image Figure 13. Aldult Image Figure 14. Global Autism Spectrum Disorder Screening Service Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Autism Spectrum Disorder Screening Service Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Autism Spectrum Disorder Screening Service Sales Value Share by Application (2021-2032) Figure 17. Global Autism Spectrum Disorder Screening Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Autism Spectrum Disorder Screening Service Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 19. North America Autism Spectrum Disorder Screening Service Sales Value (2021-2032) & (US$ Million) Figure 20. North America Autism Spectrum Disorder Screening Service Sales Value Share by Country (%), 2025 VS 2032 Figure 21. Europe Autism Spectrum Disorder Screening Service Sales Value (2021-2032) & (US$ Million) Figure 22. Europe Autism Spectrum Disorder Screening Service Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Asia-Pacific Autism Spectrum Disorder Screening Service Sales Value (2021-2032) & (US$ Million) Figure 24. Asia-Pacific Autism Spectrum Disorder Screening Service Sales Value Share by Country (%), 2025 VS 2032 Figure 25. South America Autism Spectrum Disorder Screening Service Sales Value (2021-2032) & (US$ Million) Figure 26. South America Autism Spectrum Disorder Screening Service Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Middle East & Africa Autism Spectrum Disorder Screening Service Sales Value (2021-2032) & (US$ Million) Figure 28. Middle East & Africa Autism Spectrum Disorder Screening Service Sales Value Share by Country (%), 2025 VS 2032 Figure 29. USA Autism Spectrum Disorder Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 30. USA Autism Spectrum Disorder Screening Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 31. USA Autism Spectrum Disorder Screening Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 32. Canada Autism Spectrum Disorder Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. Canada Autism Spectrum Disorder Screening Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. Canada Autism Spectrum Disorder Screening Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Mexico Autism Spectrum Disorder Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Mexico Autism Spectrum Disorder Screening Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Mexico Autism Spectrum Disorder Screening Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Germany Autism Spectrum Disorder Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Germany Autism Spectrum Disorder Screening Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Germany Autism Spectrum Disorder Screening Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. France Autism Spectrum Disorder Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. France Autism Spectrum Disorder Screening Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. France Autism Spectrum Disorder Screening Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. U.K. Autism Spectrum Disorder Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. U.K. Autism Spectrum Disorder Screening Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. U.K. Autism Spectrum Disorder Screening Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Italy Autism Spectrum Disorder Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Italy Autism Spectrum Disorder Screening Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Italy Autism Spectrum Disorder Screening Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Spain Autism Spectrum Disorder Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Spain Autism Spectrum Disorder Screening Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Spain Autism Spectrum Disorder Screening Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Russia Autism Spectrum Disorder Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Russia Autism Spectrum Disorder Screening Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Russia Autism Spectrum Disorder Screening Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Netherlands Autism Spectrum Disorder Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Netherlands Autism Spectrum Disorder Screening Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Netherlands Autism Spectrum Disorder Screening Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Nordic Countries Autism Spectrum Disorder Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Nordic Countries Autism Spectrum Disorder Screening Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Nordic Countries Autism Spectrum Disorder Screening Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. China Autism Spectrum Disorder Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. China Autism Spectrum Disorder Screening Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. China Autism Spectrum Disorder Screening Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Japan Autism Spectrum Disorder Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Japan Autism Spectrum Disorder Screening Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Japan Autism Spectrum Disorder Screening Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. South Korea Autism Spectrum Disorder Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. South Korea Autism Spectrum Disorder Screening Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. South Korea Autism Spectrum Disorder Screening Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. India Autism Spectrum Disorder Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. India Autism Spectrum Disorder Screening Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. India Autism Spectrum Disorder Screening Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Australia Autism Spectrum Disorder Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Australia Autism Spectrum Disorder Screening Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Australia Autism Spectrum Disorder Screening Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Southeast Asia Autism Spectrum Disorder Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Southeast Asia Autism Spectrum Disorder Screening Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Southeast Asia Autism Spectrum Disorder Screening Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Brazil Autism Spectrum Disorder Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Brazil Autism Spectrum Disorder Screening Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Brazil Autism Spectrum Disorder Screening Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Argentina Autism Spectrum Disorder Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Argentina Autism Spectrum Disorder Screening Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Argentina Autism Spectrum Disorder Screening Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Chile Autism Spectrum Disorder Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Chile Autism Spectrum Disorder Screening Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Chile Autism Spectrum Disorder Screening Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Colombia Autism Spectrum Disorder Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Colombia Autism Spectrum Disorder Screening Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Colombia Autism Spectrum Disorder Screening Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Peru Autism Spectrum Disorder Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Peru Autism Spectrum Disorder Screening Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Peru Autism Spectrum Disorder Screening Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Saudi Arabia Autism Spectrum Disorder Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Saudi Arabia Autism Spectrum Disorder Screening Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Autism Spectrum Disorder Screening Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Israel Autism Spectrum Disorder Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Israel Autism Spectrum Disorder Screening Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Israel Autism Spectrum Disorder Screening Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. UAE Autism Spectrum Disorder Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. UAE Autism Spectrum Disorder Screening Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. UAE Autism Spectrum Disorder Screening Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Turkey Autism Spectrum Disorder Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Turkey Autism Spectrum Disorder Screening Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Turkey Autism Spectrum Disorder Screening Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Iran Autism Spectrum Disorder Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Iran Autism Spectrum Disorder Screening Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Iran Autism Spectrum Disorder Screening Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Egypt Autism Spectrum Disorder Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Egypt Autism Spectrum Disorder Screening Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Egypt Autism Spectrum Disorder Screening Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Years Considered Figure 114. Research Process Figure 115. Key Executives Interviewed

Scope & coverage.

Types
  • Developmental Screening Service
  • Behavioral Assessment Service
Applications
  • Child
  • Aldult
Companies covered
  • Autism Speaks
  • Mayo Clinic
  • Children's Hospital of Philadelphia
  • Kaiser Permanente
  • Cleveland Clinic
  • Mind Institute at UC Davis
  • Guangdong Jinglan Technology Industry Holding Group

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Autism Spectrum Disorder Screening Service Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Autism Spectrum Disorder Screening Service Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Autism Spectrum Disorder Screening Service Market Dynamics
  1. 2.1 Autism Spectrum Disorder Screening Service Industry Trends
  2. 2.2 Autism Spectrum Disorder Screening Service Industry Drivers
  3. 2.3 Autism Spectrum Disorder Screening Service Industry Opportunities and Challenges
  4. 2.4 Autism Spectrum Disorder Screening Service Industry Restraints
3 Autism Spectrum Disorder Screening Service Market by Company
  1. 3.1 Global Autism Spectrum Disorder Screening Service Company Revenue Ranking in 2025
  2. 3.2 Global Autism Spectrum Disorder Screening Service Revenue by Company (2021-2026)
  3. 3.3 Global Autism Spectrum Disorder Screening Service Company Ranking (2024-2026)
  4. 3.4 Global Autism Spectrum Disorder Screening Service Company Manufacturing Base and Headquarters
  5. 3.5 Global Autism Spectrum Disorder Screening Service Company Product Type and Application
  6. 3.6 Global Autism Spectrum Disorder Screening Service Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Autism Spectrum Disorder Screening Service Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Autism Spectrum Disorder Screening Service Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Autism Spectrum Disorder Screening Service Market by Type
  1. 4.1 Autism Spectrum Disorder Screening Service Type Introduction
  2. 4.1.1 Developmental Screening Service
  3. 4.1.2 Behavioral Assessment Service
  4. 4.2 Global Autism Spectrum Disorder Screening Service Sales Value by Type
  5. 4.2.1 Global Autism Spectrum Disorder Screening Service Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Autism Spectrum Disorder Screening Service Sales Value by Type (2021-2032)
  7. 4.2.3 Global Autism Spectrum Disorder Screening Service Sales Value Share by Type (2021-2032)
5 Autism Spectrum Disorder Screening Service Market by Application
  1. 5.1 Autism Spectrum Disorder Screening Service Application Introduction
  2. 5.1.1 Child
  3. 5.1.2 Aldult
  4. 5.2 Global Autism Spectrum Disorder Screening Service Sales Value by Application
  5. 5.2.1 Global Autism Spectrum Disorder Screening Service Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Autism Spectrum Disorder Screening Service Sales Value by Application (2021-2032)
  7. 5.2.3 Global Autism Spectrum Disorder Screening Service Sales Value Share by Application (2021-2032)
6 Autism Spectrum Disorder Screening Service Regional Value Analysis
  1. 6.1 Global Autism Spectrum Disorder Screening Service Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Autism Spectrum Disorder Screening Service Sales Value by Region (2021-2032)
  3. 6.2.1 Global Autism Spectrum Disorder Screening Service Sales Value by Region: 2021-2026
  4. 6.2.2 Global Autism Spectrum Disorder Screening Service Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Autism Spectrum Disorder Screening Service Sales Value (2021-2032)
  7. 6.3.2 North America Autism Spectrum Disorder Screening Service Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Autism Spectrum Disorder Screening Service Sales Value (2021-2032)
  10. 6.4.2 Europe Autism Spectrum Disorder Screening Service Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Autism Spectrum Disorder Screening Service Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Autism Spectrum Disorder Screening Service Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Autism Spectrum Disorder Screening Service Sales Value (2021-2032)
  16. 6.6.2 South America Autism Spectrum Disorder Screening Service Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Autism Spectrum Disorder Screening Service Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Autism Spectrum Disorder Screening Service Sales Value Share by Country, 2025 VS 2032
7 Autism Spectrum Disorder Screening Service Country-level Value Analysis
  1. 7.1 Global Autism Spectrum Disorder Screening Service Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Autism Spectrum Disorder Screening Service Sales Value by Country (2021-2032)
  3. 7.2.1 Global Autism Spectrum Disorder Screening Service Sales Value by Country (2021-2026)
  4. 7.2.2 Global Autism Spectrum Disorder Screening Service Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Autism Spectrum Disorder Screening Service Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Autism Spectrum Disorder Screening Service Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Autism Spectrum Disorder Screening Service Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Autism Spectrum Disorder Screening Service Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Autism Spectrum Disorder Screening Service Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Autism Spectrum Disorder Screening Service Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Autism Spectrum Disorder Screening Service Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Autism Spectrum Disorder Screening Service Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Autism Spectrum Disorder Screening Service Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Autism Spectrum Disorder Screening Service Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Autism Spectrum Disorder Screening Service Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Autism Spectrum Disorder Screening Service Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Autism Spectrum Disorder Screening Service Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Autism Spectrum Disorder Screening Service Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Autism Spectrum Disorder Screening Service Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Autism Spectrum Disorder Screening Service Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Autism Spectrum Disorder Screening Service Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Autism Spectrum Disorder Screening Service Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Autism Spectrum Disorder Screening Service Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Autism Spectrum Disorder Screening Service Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Autism Spectrum Disorder Screening Service Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Autism Spectrum Disorder Screening Service Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Autism Spectrum Disorder Screening Service Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Autism Spectrum Disorder Screening Service Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Autism Spectrum Disorder Screening Service Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Autism Spectrum Disorder Screening Service Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Autism Spectrum Disorder Screening Service Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Autism Spectrum Disorder Screening Service Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Autism Spectrum Disorder Screening Service Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Autism Spectrum Disorder Screening Service Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Autism Spectrum Disorder Screening Service Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Autism Spectrum Disorder Screening Service Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Autism Spectrum Disorder Screening Service Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Autism Spectrum Disorder Screening Service Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Autism Spectrum Disorder Screening Service Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Autism Spectrum Disorder Screening Service Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Autism Spectrum Disorder Screening Service Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Autism Spectrum Disorder Screening Service Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Autism Spectrum Disorder Screening Service Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Autism Spectrum Disorder Screening Service Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Autism Spectrum Disorder Screening Service Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Autism Spectrum Disorder Screening Service Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Autism Spectrum Disorder Screening Service Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Autism Spectrum Disorder Screening Service Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Autism Spectrum Disorder Screening Service Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Autism Spectrum Disorder Screening Service Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Autism Spectrum Disorder Screening Service Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Autism Spectrum Disorder Screening Service Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Autism Spectrum Disorder Screening Service Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Autism Spectrum Disorder Screening Service Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Autism Spectrum Disorder Screening Service Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Autism Spectrum Disorder Screening Service Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Autism Spectrum Disorder Screening Service Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Autism Spectrum Disorder Screening Service Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Autism Spectrum Disorder Screening Service Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Autism Spectrum Disorder Screening Service Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Autism Spectrum Disorder Screening Service Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Autism Spectrum Disorder Screening Service Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Autism Spectrum Disorder Screening Service Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Autism Spectrum Disorder Screening Service Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Autism Spectrum Disorder Screening Service Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Autism Spectrum Disorder Screening Service Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Autism Spectrum Disorder Screening Service Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Autism Spectrum Disorder Screening Service Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Autism Spectrum Disorder Screening Service Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Autism Spectrum Disorder Screening Service Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Autism Spectrum Disorder Screening Service Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Autism Spectrum Disorder Screening Service Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Autism Spectrum Disorder Screening Service Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Autism Spectrum Disorder Screening Service Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Autism Spectrum Disorder Screening Service Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Autism Spectrum Disorder Screening Service Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Autism Spectrum Disorder Screening Service Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Autism Spectrum Disorder Screening Service Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Autism Spectrum Disorder Screening Service Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Autism Spectrum Disorder Screening Service Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Autism Spectrum Disorder Screening Service Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Autism Spectrum Disorder Screening Service Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Autism Spectrum Disorder Screening Service Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Autism Spectrum Disorder Screening Service Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Autism Spectrum Disorder Screening Service Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Autism Spectrum Disorder Screening Service Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Autism Spectrum Disorder Screening Service Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Autism Spectrum Disorder Screening Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Autism Speaks
  2. 8.1.1 Autism Speaks Company Information
  3. 8.1.2 Autism Speaks Business Overview
  4. 8.1.3 Autism Speaks Autism Spectrum Disorder Screening Service Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Autism Speaks Autism Spectrum Disorder Screening Service Product Portfolio
  6. 8.1.5 Autism Speaks Recent Developments
  7. 8.2 Mayo Clinic
  8. 8.2.1 Mayo Clinic Company Information
  9. 8.2.2 Mayo Clinic Business Overview
  10. 8.2.3 Mayo Clinic Autism Spectrum Disorder Screening Service Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Mayo Clinic Autism Spectrum Disorder Screening Service Product Portfolio
  12. 8.2.5 Mayo Clinic Recent Developments
  13. 8.3 Children's Hospital of Philadelphia
  14. 8.3.1 Children's Hospital of Philadelphia Company Information
  15. 8.3.2 Children's Hospital of Philadelphia Business Overview
  16. 8.3.3 Children's Hospital of Philadelphia Autism Spectrum Disorder Screening Service Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Children's Hospital of Philadelphia Autism Spectrum Disorder Screening Service Product Portfolio
  18. 8.3.5 Children's Hospital of Philadelphia Recent Developments
  19. 8.4 Kaiser Permanente
  20. 8.4.1 Kaiser Permanente Company Information
  21. 8.4.2 Kaiser Permanente Business Overview
  22. 8.4.3 Kaiser Permanente Autism Spectrum Disorder Screening Service Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Kaiser Permanente Autism Spectrum Disorder Screening Service Product Portfolio
  24. 8.4.5 Kaiser Permanente Recent Developments
  25. 8.5 Cleveland Clinic
  26. 8.5.1 Cleveland Clinic Company Information
  27. 8.5.2 Cleveland Clinic Business Overview
  28. 8.5.3 Cleveland Clinic Autism Spectrum Disorder Screening Service Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Cleveland Clinic Autism Spectrum Disorder Screening Service Product Portfolio
  30. 8.5.5 Cleveland Clinic Recent Developments
  31. 8.6 Mind Institute at UC Davis
  32. 8.6.1 Mind Institute at UC Davis Company Information
  33. 8.6.2 Mind Institute at UC Davis Business Overview
  34. 8.6.3 Mind Institute at UC Davis Autism Spectrum Disorder Screening Service Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Mind Institute at UC Davis Autism Spectrum Disorder Screening Service Product Portfolio
  36. 8.6.5 Mind Institute at UC Davis Recent Developments
  37. 8.7 Guangdong Jinglan Technology Industry Holding Group
  38. 8.7.1 Guangdong Jinglan Technology Industry Holding Group Company Information
  39. 8.7.2 Guangdong Jinglan Technology Industry Holding Group Business Overview
  40. 8.7.3 Guangdong Jinglan Technology Industry Holding Group Autism Spectrum Disorder Screening Service Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Guangdong Jinglan Technology Industry Holding Group Autism Spectrum Disorder Screening Service Product Portfolio
  42. 8.7.5 Guangdong Jinglan Technology Industry Holding Group Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research